
IUPAC name
(2R)-3-phenyl-2-{[4-(propan-2-yl)cyclohexyl]formamido}propanoic acid
SMILES
CC(C)C1CC[C@@H](CC1)C(=O)N[C@H](CC1=CC=CC=C1)C(O)=O
Compound class
Hypoglycemic Agents; Meglitinides; Drugs Used in Diabetes; Alimentary Tract and Metabolism; Blood Glucose Lowering Drugs, Excl. Insulins; Cytochrome P-450 CYP2C9 Inhibitors; Cytochrome P-450 CYP2C9 Inducers; CYP2D6 Inducers; CYP2D6 Inducers (strong); CYP3A4 Inhibitors;
Therapeutic area
For the treatment of non-insulin dependent-diabetes mellitus in conjunction with diet and exercise.
Common name
Nateglinide
IUPAC name
(2R)-3-phenyl-2-{[4-(propan-2-yl)cyclohexyl]formamido}propanoic acid
SMILES
CC(C)C1CC[C@@H](CC1)C(=O)N[C@H](CC1=CC=CC=C1)C(O)=O
INCHI
InChI=1S/C19H27NO3/c1-13(2)15-8-10-16(11-9-15)18(21)20-17(19(22)23)12-14-6-4-3-5-7-14/h3-7,13,15-17H,8-12H2,1-2H3,(H,20,21)(H,22,23)/t15?,16-,17-/m1/s1
FORMULA
C19H27NO3

Common name
Nateglinide
IUPAC name
(2R)-3-phenyl-2-{[4-(propan-2-yl)cyclohexyl]formamido}propanoic acid
Molecular weight
317.423
clogP
3.270
clogS
-3.477
HBond Acceptor
3
HBond Donor
2
Total Polar Surface Area
66.4
Number of Rings
2
Rotatable Bond
6
Drug ID | Common name | Structure CAS | SMILE | Frequency |
---|---|---|---|---|
FDBF00003 | formamide |
![]() |
C(=O)N | 0.1240 |
FDBF00004 | acetic acid |
![]() |
CC(=O)O | 0.0687 |
FDBF00005 | benzene |
![]() |
c1ccccc1 | 0.2824 |
FDBF00007 | propane |
![]() |
C(C)C | 0.2412 |
FDBF00023 | toluene |
![]() |
c1(ccccc1)C | 0.1268 |
FDBF00047 | propionic acid |
![]() |
CCC(=O)O | 0.0395 |
FDBF00355 | cyclohexane |
![]() |
C1CCCCC1 | 0.0127 |
FDBF01696 | cyclohexanecarboxamide |
![]() |
C1(CCCCC1)C(=O)N | 0.0003 |
FDBF01697 | isopropylcyclohexane |
![]() |
C(C)(C)C1CCCCC1 | 0.0003 |
FDBF01698 | 3-phenylpropanoic acid |
![]() |
C(C(=O)O)Cc1ccccc1 | 0.0014 |